Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
about
Naturally occurring food toxinsPharmacokinetic and Metabolic Characteristics of Herb-Derived Khellactone Derivatives, A Class of Anti-HIV and Anti-Hypertensive: A ReviewInsights into CYP2B6-mediated drug-drug interactionsGrowth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinomaA kinetic study of the main guaco metabolites using syrup formulation and the identification of an alternative route of coumarin metabolism in humansSpecies differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactionsNatural personal care products-analysis of ingredient lists and legal situationIn vitro evaluation of hepatic and extra-hepatic metabolism of coumarins using rat subcellular fractions: correlation of in vitro clearance with in vivo data.A Method for LC-MS/MS Profiling of Coumarins in Zanthoxylum zanthoxyloides (Lam.) B. Zepernich and Timler Extracts and Essential Oils.Flavored little cigar smoke induces cytotoxicity and apoptosis in airway epithelia.Effects of psoralens as anti-tumoral agents in breast cancer cells.Review on natural coumarin lead compounds for their pharmacological activityAnalysis and distribution of esculetin in plasma and tissues of rats after oral administration.Metabolites identification of Huo Luo Xiao Ling Dan in rat urine by UPLC coupled with electrospray ionization time-of-flight mass spectrometry.6-7-Dimethoxy-4-methylcoumarin suppresses pro-inflammatory mediator expression through inactivation of the NF-κB and MAPK pathways in LPS-induced RAW 264.7 cells.Scented grasses in Norway--identity and usesQuantitation of Ten Flavor Compounds in Unburned Tobacco Products.Fern rhizomes as fodder in NorwayCYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?Gustatory Receptors Required for Avoiding the Toxic Compound Coumarin in Drosophila melanogasterEffects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in miceAntihyperglycemic and antioxidant activities of twig extract from Cinnamomum osmophloeum.4-methylcoumarin derivatives inhibit human neutrophil oxidative metabolism and elastase activity.Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian PopulationDifferential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl ether.A review of the electrophilic reaction chemistry involved in covalent DNA binding.Bioactivation of herbal constituents: simple alerts in the complex system.Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices.In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science.Pharmacogenomics of Scopoletin in Tumor Cells.New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative AgentsAntinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain.In vivo chemotherapeutic insight of a novel isocoumarin (3-hexyl-5,7-dimethoxy-isochromen-1-one): Genotoxicity, cell death induction, leukometry and phagocytic evaluation.p-Sulfonic Acid Calix[4]arene as an Efficient Catalyst for One-Pot Synthesis of Pharmaceutically Significant Coumarin Derivatives under Solvent-Free Condition.Deciphering the role of coumarin as a novel quorum sensing inhibitor suppressing virulence phenotypes in bacterial pathogens.Assessment of the genotoxic/clastogenic potential of coumarin derivative 6,7-dihydroxycoumarin (aesculetin) in multiple mouse organs.Genotoxicity of Nicotiana tabacum leaves on Helix aspersa.Zirconia-based catalyst for the one-pot synthesis of coumarin through Pechmann reaction.The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipelineMolecular modelling of CYP2F substrates: comparison of naphthalene metabolism by human, rat and mouse CYP2F subfamily enzymes.
P2860
Q24620433-4E174893-146A-4CD7-865E-885B7AE0C440Q26752603-12BE3DF2-39F6-48B6-95BA-3FD7B0582273Q28078857-48B87681-DB3D-4227-9B42-ACA602018E1CQ28483934-06A8BE1E-211C-41F5-8C54-97FD7F6314C6Q28543941-E85F8E7B-345F-4348-9E83-24B3453A9736Q28580249-B7E021D8-A16E-4039-82A0-8A7AB25AA723Q28828252-EE98B1D6-4252-42B0-835F-65A93D68D1E0Q33423100-CAC4C0BB-7901-45DF-ACC8-97D4146512D6Q33469674-22E3D4FF-F3C5-4420-9470-9E74DBD98EE0Q33595042-DE34ABAC-290A-47BE-99D0-5208DBA6BBAAQ34023669-18F274F7-40E8-49C2-ACEB-AFB1A8E44C88Q34339290-5C1B1541-D0BF-417A-AD71-E0F5C2AFDFC7Q34872174-D5C291A4-CCC7-489B-8982-D774617C5D7DQ35691312-4C281788-2A83-4227-9122-462F2416E562Q35727586-380DA459-5DA5-4E49-9E2F-D2A877558512Q35877804-73022B2B-F5C5-40F5-B55C-EB8EC0F038E0Q36073351-6F21F7C5-D300-4134-9546-1B3DAE5A794CQ36124514-43843AC4-7A39-4A4C-967A-BC73116F2083Q36730627-20E50198-0FF4-464D-A192-CE1B307C6564Q36835369-AE139DE0-0678-4F9D-AE90-926EDFC4BC15Q36980315-464DE499-0650-482A-B507-D322B9F153CFQ37074779-C588B551-FE5F-433E-9CB0-F8C71459CF43Q37115064-0478C0DF-6FBA-4314-A838-31673805744EQ37292058-99F6CAF9-40A0-42C4-8B70-4743928D8823Q37330641-D1F05BEC-4128-4DE9-8A35-79C3FC2C6D3AQ37781059-02CB0EB0-7AD5-4A70-81D7-AD2414E0C6FAQ37879144-7E265E46-B0CE-42D1-B8CC-AF02D0E501D6Q38058138-184296F7-8879-434B-A075-1B55172D7A2BQ38651631-A2B1287C-C370-4B42-A218-B7189A62C3F3Q38777193-7B1E750A-9895-4107-A6E2-AC0701AB8EFEQ40013218-27C862B9-DCFC-4A27-855B-5506781BDE87Q40358265-CFC4C24A-994E-4410-A141-4D7A8834014AQ41177452-EE1906EC-FD20-4F32-9C4F-FA5A6D412442Q41341059-5191F8A0-DC17-4F26-A2DE-92BA1BE89EDDQ41489467-2FD25C21-9222-4741-9AFC-9FEF3DB311BCQ41680576-CA268580-C0D5-4913-8FCA-06E12C49BC45Q41809381-C8C159ED-5BE4-47D1-906E-020EAF805BF6Q42125874-6E2393C9-EFBE-43EA-91B8-2C70ABF56126Q42583215-25B5E910-1C50-4781-B69D-6F7DB491FBE7Q43090793-A4E0B7E5-7570-4C90-9458-ED1C48C403B2
P2860
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@ast
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@en
type
label
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@ast
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@en
prefLabel
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@ast
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@en
P1476
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
@en
P2093
P304
P356
10.1016/S0278-6915(99)00010-1
P577
1999-04-01T00:00:00Z